Copyright
©The Author(s) 2025.
World J Clin Pediatr. Dec 9, 2025; 14(4): 107290
Published online Dec 9, 2025. doi: 10.5409/wjcp.v14.i4.107290
Published online Dec 9, 2025. doi: 10.5409/wjcp.v14.i4.107290
Figure 1 The flowchart of the study.
U-JIA: Uveitis associated with juvenile idiopathic arthritis; MTX: Methotrexate; bDMARDs: Biologic disease-modifying anti-rheumatic drugs.
Figure 2 The main eye surgeries in the patients with uveitis.
Figure 3 Kaplan-Meier curves.
A: The probability of the remission achievement on methotrexate depending on the surgical intervention; B: The probability of biologic disease-modifying antirheumatic drug initiation depending on the surgical intervention; C: The probability of not having surgical intervention depending on the initiation time of methotrexate. bDMARDs: Biologic disease-modifying anti-rheumatic drugs.
Figure 4 The most common complications of uveitis associated with juvenile idiopathic arthritis.
A: Band keratopathy (arrow); B Posterior synechia (arrow).
- Citation: Yakovlev AA, Gaidar EV, Sorokina LS, Nikitina TN, Chikova IA, Kalashnikova OV, Kostik MM. Features of patients with uveitis associated with juvenile idiopathic arthritis required eye surgery. World J Clin Pediatr 2025; 14(4): 107290
- URL: https://www.wjgnet.com/2219-2808/full/v14/i4/107290.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v14.i4.107290
